Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01789073
NCT01789073
Completed
Not Applicable

Randomized, Controlled Trial Investigating the Effect of Preoperative Oral Immunonutrition on Complications and Length of Hospital Stay After Elective Surgery for Pancreatic Cancer

University of Copenhagen1 site in 1 country35 target enrollmentFebruary 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPancreatic Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Cancer
Sponsor
University of Copenhagen
Enrollment
35
Locations
1
Primary Endpoint
Overall postoperative complications after major gastrointestinal (GI) elective surgery.
Status
Completed
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to investigate the effect of preoperative immunonutrition on complications and length of hospital stay in patients with pancreatic cancer undergoing elective surgery.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
December 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Arne Astrup

Chief of Institute of Human Nutrition

University of Copenhagen

Eligibility Criteria

Inclusion Criteria

  • •Men and women referred to treatment at Surgical Gastroenterology Clinic C, Ward 2122 for pancreatic cancer
  • •Age \> 18 years.

Exclusion Criteria

  • •Age \< 18 years
  • •Pregnant and lactating women
  • •Persons who cannot understand and/or speak Danish
  • •Renal dysfunction
  • •Milk allergy
  • •Participants are excluded if elective surgery is not indicated after all

Outcomes

Primary Outcomes

Overall postoperative complications after major gastrointestinal (GI) elective surgery.

Time Frame: Within the first 30 days after surgery

Secondary Outcomes

  • Length of hospital stay after major gastrointestinal (GI) elective surgery(Within the first 30 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Phase 3
Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant ChemoradiotherapyEsophageal Neoplasms
NCT04513418Hecheng Li M.D., Ph.D244
Completed
Not Applicable
Effects of Perioperative Immunonutrition in Patients With Head and Neck CancerHead and Neck CancerNutrition, Healthy
NCT06318221TC Erciyes University34
Recruiting
Phase 3
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)Bladder CancerInterstitial CystitisPainful Bladder SyndromeNeurogenic BladderHemorrhagic CystitisEndometriosisBladder Disease
NCT05726786Centre Hospitalier Universitaire Vaudois232
Withdrawn
Early Phase 1
Preoperative Oral ImmunoNuTrition to Improve Surgical Outcomes for IBD Patients (PINT)Inflammatory Bowel Diseases
NCT03333148University of Alabama at Birmingham
Unknown
Phase 4
Immunonutrition and Thoracoabdominal Aorta Aneurysm RepairThoracic Aortic AneurysmRespiratory Insufficiency
NCT00339053St. Antonius Hospital142